CLINICAL TRIAL OF THROMBOLYSIS IN MYOCARDIAL INFARCATION

承包商将作为NHLBI的协调中心 题为“心肌溶栓”的合作临床试验 脑梗塞(TIMI)。该试验的目标是评估一种 溶栓剂可缩小梗塞面积，从而改善 心功能和随后的发病率和死亡率。这个 协调中心的主要职责是参与 第一阶段试验的设计以及收集、编辑、 存储和分析由临床单位和中心生成的数据 招募期间的实验室，第二阶段。协调 中心将在终止后的18个月内提供支持 进行征聘，以便能够分析和传播试验结果。

The contractor will serve as the coordinating center for NHLBI's collaborative clinical trial entitled "Thrombolysis in Myocardial Infarction (TIMI)". The goal of the trial is to assess the efficacy of a thrombolytic agent in reducing infarct size and thereby improving ventricular function and subsequent morbidity and mortality. The coordinating centerwill have as its major responsibilities participation in the design of the trial during Phase I as well as collecting, editing, storing, and analyzing data generated by the clinical units and central laboratories during the recruitment period, Phase II. The coordinating center will be supported for eighteen months beyond termination of recruitment to permit analysis and dissemination of trial findings.